Co-Chair of the Firm's Cannabis Industry Group Irina Dashevsky will participate on the Cannabis in Interstate Commerce panel on May 4 at 2:00pm ET, sponsored by the International Cannabis Bar Association and Sacramento County Bar Association, Cannabis Law Section.
Non-hemp cannabis is legal for cultivation, manufacture, sale, uses under the medical programs of 36 states, the District of Columbia, and several U.S. territories. More than one-third of those jurisdictions also permit non-medical or adult-use. Because non-hemp cannabis remains a controlled substance under federal law, it cannot be sold, transported, or shipped across state lines, creating a patchwork of interstate cannabis economies.
In this 90-minute program, panelists will discuss a range of topics related to the interstate commerce ban, including licensee residency requirements adopted in many states (and associated litigation); the Dormant Commerce Clause; economic and social equity implications of closed markets; and the possibility of interstate compacts as a stopgap pending federal legalization. Speakers will also address the ban’s impact on medical patients and how pending legislation and post-legalization regulatory schemes may impact licensed operators and other industry participants.
For more information, click here.
Sign up for our newsletter and get the latest to your inbox.